| HOME >> BIOLOGY >> TECHNOLOGY |
------------ ------------ ------------ ------------
------------ ------------ ------------ ------------
65,195 361,945 95,724 534,154
------------ ------------ ------------ ------------
Net loss and
comprehensive loss
for the period (6,414,856) (3,225,371) (11,431,911) (6,453,782)
Deficit - Beginning
of period (61,176,218) (43,968,897) (56,159,163) (40,740,486)
------------ ------------ ------------ ------------
------------ ------------ ------------ ------------
Deficit - End of
period (67,591,074) (47,194,268) (67,591,074) (47,194,268)
------------ ------------ ------------ ------------
------------ ------------ ------------ ------------
Loss per share -
basic and diluted (0.25) (0.15) (0.44) (0.31)
------------ ------------ ------------ ------------
------------ ------------ ------------ ------------
Weighted average
shares outstanding 25,937,476 22,089,356 25,936,634 20,511,557
------------ ------------ ------------ ------------
------------ ------------ ------------ ------------
SemBioSys Genetics Inc.
Consolidated Statements of Cash Flows
(Unaudited)
-------------------------------------------------------------------------
(expressed in Canadian dollars)
Three month period ended Six month period ended
June 30, June 30, June 30, June 30,
2008 2007
'/>"/>
| SOURCE SemBioSys Genetics Inc. Copyright©2008 PR Newswire. All rights reserved |